(Q53171426)

12 May 2018

title

[Measles virus: a future therapeutic agent in oncology?]. (English)

1 reference

12 May 2018

1 reference

Yann Touchefeu

1

1 reference

12 May 2018

Ulrike Schick

series ordinal

2

1 reference

12 May 2018

Kevin J Harrington

series ordinal

3

1 reference

12 May 2018

language of work or name

French

0 references

publication date

25 April 2012

1 reference

12 May 2018

published in

médecine/sciences

1 reference

12 May 2018

volume

28

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

388-394

1 reference

12 May 2018

Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus

cites work

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Regression of Burkitt's lymphoma in association with measles infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Measles virus receptors: SLAM and CD46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

An immunocompetent murine model for oncolysis with an armed and targeted measles virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Detection of measles vaccine in the throat of a vaccinated child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Measles inclusion-body encephalitis caused by the vaccine strain of measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Intelligent design: combination therapy with oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Oncolytic viruses in radiation oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F2012284016

10.1051/MEDSCI/2012284016

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

0 references

1 reference

12 May 2018